CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Nov. 02, 2013	Oct. 27, 2012
Operating activities
Net income	$ 5,123	$ 5,756
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	257	136
Amortization of trademarks	712	1,069
Deferred income taxes	(441)	(371)
Stock-based compensation including tax effect	788	647
Other, net	(44)	(181)
Changes in operating assets and liabilities:
Receivables	(984)	(1,256)
Prepaid expenses and other current assets	61	(513)
Income taxes receivable, net	779	275
Accounts payable and other accrueds	(197)	960
Deferred revenue	(6)	(216)
Accrued compensation	181	(219)
Other accrued liabilities	245	1,137
Net cash provided by operating activities	6,474	7,224
Investing activities
Purchase of property and equipment	(513)	(403)
Purchases of trademarks, including registration and renewal costs	(17)	(13,836)
Net cash used in investing activities	(530)	(14,239)
Financing activities
Proceeds from JP Morgan term loan		13,000
Payments of US Bank Term Loan and promissory note		(6,938)
Payments of JP Morgan Term Loan	(2,422)
Proceeds from exercise of stock options	36	67
Dividends	(2,520)	(5,030)
Net cash used in financing activities	(4,906)	1,099
Increase (decrease) in cash and cash equivalents	1,038	(5,916)
Cash and cash equivalents at beginning of period	2,424	7,421
Cash and cash equivalents at end of period	3,462	1,505
Cash paid during period for:
Income taxes	2,498	1,481
Interest	349	138
Non-cash financing activities:
Accrued and declared dividends	$ 840	$ 840